SPRB Valuation

Spruce Biosciences Inc

Add to Watchlist

Advanced Chart

0.000

-0.079(-100.509%)1D

Overview
Forecast
Valuation
Earnings

SPRB Relative Valuation

SPRB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SPRB is overvalued; if below, it's undervalued.

Historical Valuation

Spruce Biosciences Inc (SPRB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.38. The fair price of Spruce Biosciences Inc (SPRB) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：0.08

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.19

P/B

Median3y

0.67

Median5y

0.88

-1020.94

FCF Yield

Median3y

-142.90

Median5y

-101.15

Competitors Valuation Multiple

The average P/S ratio for SPRB's competitors is 0.00, providing a benchmark for relative valuation. Spruce Biosciences Inc Corp (SPRB) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

SPRB.O

Spruce Biosciences Inc

Loss

Average P/S: 0.00

-100.00%